Lidocaine group | Control group | p-value | |
---|---|---|---|
The total amount of used microspheres (ml- SD) | 6.9 ± 2.5 | 9.7 ± 2.8 | p < 0.19 |
Dominant fibroid volume reduction (three months control) | 84.4 ± 92 cm3 | 145.1 ± 175 cm3 | p < 0.15 |
Total uterine volume | 161,7 ± 154 cm3 | 261,9 ± 288 cm3 | P < 0.26 |
Total fibroid burden infarction | p < 0.86 | ||
100% or 90–99%-fibroid infraction | 18 (94%) | 14 (95%) | |
< 90% fibroid infarction | 2 (6%) | 2 (5%) |